Voloridge Investment Management
KNSA icon

Voloridge Investment Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Voloridge Investment Management’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-134,516
Closed -$6.48M – 952
2026
Q1 		$6.48M Sell
134,516
-94,417
-41% -$4.18M 0.03% 620
2025
Q4 		$9.44M Sell
228,933
-69,414
-23% -$2.78M 0.03% 595
2025
Q3 		$11.6M Sell
298,347
-35,576
-11% -$1.16M 0.04% 501
2025
Q2 		$9.24M Buy
333,923
+268,813
+413% +$6.84M 0.03% 568
2025
Q1 		$1.45M Sell
65,110
-75,768
-54% -$1.56M 0.01% 1004
2024
Q4 		$2.79M Sell
140,878
-49,108
-26% -$1.12M 0.01% 897
2024
Q3 		$4.75M Buy
189,986
+164,200
+637% +$4M 0.02% 789
2024
Q2 		$481K Sell
25,786
-8,276
-24% -$155K ﹤0.01% 1124
2024
Q1 		$672K Buy
+34,062
New +$665K ﹤0.01% 1022
2020
Q3 		– Sell
-12,036
Closed -$307K – 1369
2020
Q2 		$307K Buy
+12,036
New +$251K ﹤0.01% 1136

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Voloridge Investment Management's KNSA Position: Q2 2026 in Review

Voloridge Investment Management sold out of Kiniksa Pharmaceuticals (KNSA) in Q2 2026, closing a stake of 134,516 shares — an estimated $6.48M sold.

Voloridge Investment Management first reported a position in KNSA in Q2 2020 and held it in 10 quarters. The position peaked at $11.6M in Q3 2025. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • Voloridge Investment Management reported no remaining Kiniksa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Voloridge Investment Management sold 134,516 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $6.48M.
  • Voloridge Investment Management first reported a position in Kiniksa Pharmaceuticals in Q2 2020 and held it in 10 quarters.
  • Voloridge Investment Management's Kiniksa Pharmaceuticals position peaked at $11.6M in Q3 2025.
  • 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Voloridge Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.